Đang chuẩn bị liên kết để tải về tài liệu:
SMAD4–201 transcript as a putative biomarker in colorectal cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Transcripts with alternative 5′-untranslated regions (UTRs) result from the activity of alternative promoters and they can determine gene expression by influencing its stability and translational efficiency, thus executing complex regulation of developmental, physiological and pathological processes. | Babic et al. BMC Cancer 2022 22 72 https doi.org 10.1186 s12885-022-09186-z RESEARCH Open Access SMAD4 201 transcript as a putative biomarker in colorectal cancer Tamara Babic1 Sandra Dragicevic1 Marko Miladinov2 Zoran Krivokapic2 3 4 and Aleksandra Nikolic1 Abstract Background Transcripts with alternative 5 -untranslated regions UTRs result from the activity of alternative promot- ers and they can determine gene expression by influencing its stability and translational efficiency thus executing complex regulation of developmental physiological and pathological processes. Transcriptional regulation of human SMAD4 a key tumor suppressor deregulated in most gastrointestinal cancers entails four alternative promoters. These promoters and alternative transcripts they generate remain unexplored as contributors to the SMAD4 deregulation in cancer. The aim of this study was to investigate the relative abundance of the transcript SMAD4 201 in colorectal cell lines and tissues in order to establish if its fluctuations may be associated with colorectal cancer CRC . Methods Relative abundance of SMAD4 201 in total SMAD4 mRNA was analyzed using quantitative PCR in a set of permanent human colon cell lines and tumor and corresponding healthy tissue samples from patients with CRC. Results The relative abundance of SMAD4 201 in analyzed cell lines varied between 16 and 47 . A similar relative abundance of SMAD4 201 transcript was found in the majority of analyzed human tumor tissue samples and it was averagely 20 lower in non-malignant in comparison to malignant tissue samples p 0.001 . Transcript SMAD4 202 was not detectable in any of the analyzed samples so the observed fluctuations in the composition of SMAD4 tran- scripts can be attributed to transcripts other than SMAD4 201 and SMAD4 202. Conclusion The expression profile of SMAD4 201 in human tumor and non-tumor tissue samples may indicate the translational potential of this molecule in CRC but further research is needed .